GlobeNewsWire · MGNX · October 26, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Get the app for more

Explore stock news, insights and company research.